Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 30, 1995 - Issue 9
Submit an article Journal homepage
66
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Omeprazole in the Long-Term Treatment of Gastro-oesophageal Reflux Disease: A Double-Blind Randomized Dose-Finding Study

L. Sterk Laursen Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
T. Havelund Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
S. Bondesen Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
J. Hansen Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
G. Sanchez Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
E. Sebelin Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
,
C. Fenger Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
&
K. Lauritsen Depts. of Medical Gastroenterology and Pathology, Odense University Hospital, Odense, Denmark
 show all
Pages 839-846 | Received 18 Nov 1994, Accepted 30 Jan 1995, Published online: 08 Jul 2009

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Keith G Tolman, Jane Chandramouli & John C Fang. (2000) Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Expert Opinion on Pharmacotherapy 1:6, pages 1171-1194.
Read now
Tehillah Menes, Shlomo Lelcuk & Hadar Spivak. (2000) Pathogenesis and Current Management of Gastro-oesophageal-reflux-related Asthma. The European Journal of Surgery 166:8, pages 596-601.
Read now
M. Viljakka, J. Nevalainen & J. Isolauri. (1997) Lifetime Costs of Surgical versus Medical Treatment of Severe Gastro-Oesophageal Reflux Disease in Finland. Scandinavian Journal of Gastroenterology 32:8, pages 766-772.
Read now

Articles from other publishers (35)

Hiroto Miwa, Ataru Igarashi, Lida Teng, Akihito Uda, Hisato Deguchi & Toshiro Tango. (2019) Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease. Journal of Gastroenterology 54:8, pages 718-729.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 334 341 .
Sachio Hata, Makoto Arai, Daisuke Maruoka, Takeshi Tanaka, Tomoaki Matsumura, Takuto Suzuki, Tomoo Nakagawa, Tatsuro Katsuno, Fumio Imazeki & Osamu Yokosuka. (2013) Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: A randomized crossover study. Clinics and Research in Hepatology and Gastroenterology 37:3, pages 296-301.
Crossref
. (2011) Doença do refluxo gastroesofágico: tratamento farmacológico. Revista da Associação Médica Brasileira 57:6, pages 617-628.
Crossref
. (2011) Gastroesophageal reflux disease: drug therapy. Revista da Associação Médica Brasileira (English Edition) 57:6, pages 603-614.
Crossref
. (2011) Gastroesophageal reflux disease: drug therapy. Revista da Associação Médica Brasileira 57:6, pages 603-614.
Crossref
Mohammad Yaghoobi, Sara Padol, Yuhong Yuan & Richard H. Hunt. (2010) Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European Journal of Gastroenterology & Hepatology 22:5, pages 583-590.
Crossref
Akihito Nagahara, Mariko Hojo, Daisuke Asaoka & Sumio Watanabe. (2010) Maintenance therapy of gastroesophageal reflux disease. Clinical Journal of Gastroenterology 3:2, pages 61-68.
Crossref
Clare Donnellan, Cathy Preston, Paul Moayyedi & Nav Sharma. (2010) Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database of Systematic Reviews.
Crossref
Tomohiko Shimatani, Masaki Inoue, Tomoko Kuroiwa, Mutsuko Moriwaki, Jing Xu, Kazuro Ikawa, Norifumi Morikawa & Susumu Tazuma. (2007) Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers. Digestive Diseases and Sciences 52:2, pages 390-395.
Crossref
Henry Cohen, Joaquim Prado P. Moraes-Filho, Maria Luisa Cafferata, Giselle Tomasso, Graciela Salis, Oscar Gonz??lez, Jorge Valenzuela, Prateek Sharma, Peter Malfertheiner, David Armstrong, Lars Lundell, Rodolfo Corti, Paulo Sakai & Ivan Ceconello. (2006) An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease. European Journal of Gastroenterology & Hepatology 18:4, pages 349-368.
Crossref
Ernst Eypasch, Edmund A.M. Neugebauer, F. Fischer, Hans Troidl, A.L. Blum, D. Collet, A. Cuschieri, B. Dallemagne, H. Feussner, K.-H. Fuchs, H. Glise, C.K. Kum, T. Lerut, L. Lundell, H.E. Myrvold, A. Peracchia, H. Petersen & J.J.B. van Lanschot. 2006. EAES Guidelines for Endoscopic Surgery. EAES Guidelines for Endoscopic Surgery 97 124 .
Clare Donnellan, Cathy Preston, Paul Moayyedi & Nav Sharma. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Bonnie B. Dean, Anacleto D. GanoJrJr, Kevin Knight, Joshua J. Ofman & Ronnie Fass. (2004) Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clinical Gastroenterology and Hepatology 2:8, pages 656-664.
Crossref
Per M. Hellström & Sigurd Vitols. (2004) The Choice of Proton Pump Inhibitor: Does it matter?. Basic & Clinical Pharmacology & Toxicology 94:3, pages 106-111.
Crossref
A. Chandra, R. Moazzez, D. Bartlett, A. Anggiansah & W.J. Owen. (2004) A review of the atypical manifestations of gastroesophageal reflux disease. International Journal of Clinical Practice 58:1, pages 41-48.
Crossref
Tomoyuki Yokota, Hidetaka Matsui, Bunzo Matsuura, Kazutaka Maeyama & Morikazu Onji. (2003) Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells. European Journal of Pharmacology 481:2-3, pages 233-240.
Crossref
S Contini & C Scarpignato. (2003) Endoscopic treatment of gastro-oesophageal reflux disease (GORD): a systematic review. Digestive and Liver Disease 35:11, pages 818-838.
Crossref
Peter G Gibson, Richard Henry & Jennifer JL Coughlan. (2003) Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Ron Goeree, Bernie J. O'Brien, Gordon Blackhouse, John Marshall, Andrew Briggs & Rameeta Lad. (2002) Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn. Value in Health 5:4, pages 312-328.
Crossref
G. Holtmann, P. Bytzer, M. Metz, V. Loeffler & A. L. Blum. (2002) A randomized, double‐blind, comparative study of standard‐dose rabeprazole and high‐dose omeprazole in gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 16:3, pages 479-485.
Crossref
Sanjay Nandurkar & Nicholas J. Talley. (2000) Epidemiology and natural history of reflux disease. Best Practice & Research Clinical Gastroenterology 14:5, pages 743-757.
Crossref
Ph. Houcke, D. Goldfain, P. Guyot, Th. Helbert, J. Laurent, J. F. Rey, D. Rouhier, J. Cassigneul, B. Marchetti, A. Papazian & M. Laurence. (2000) Prévention des récidives de l’oesophagite par reflux par le lansoprazole: 30 mg un jour sur deux ou 15 mg tous les jours?Prevention of relapse of gastro-oesophageal reflux disease by lansoprazole: 30 mg every other day or 15 mg daily?. Acta Endoscopica 30:3, pages 243-253.
Crossref
Edmund Neugebauer & Stefan Sauerland. 2000. Recommendations for evidence-based endoscopic surgery. Recommendations for evidence-based endoscopic surgery 47 62 .
Kenneth R. DeVault. (1999) OVERVIEW OF MEDICAL THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE. Gastroenterology Clinics of North America 28:4, pages 831-845.
Crossref
Escourrou, Deprez, Saggioro, Geldof, Fischer & Maier. (2001) Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 13:11, pages 1481-1491.
Crossref
C. J. Van Rensburg, Honiball, J. H. Van Zyl, H. DE K. Grundling, Eloff, Spies, Simjee, Theron, Fischer & Louw. (2001) Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis—a 2‐year follow‐up. Alimentary Pharmacology & Therapeutics 13:8, pages 1023-1028.
Crossref
Henk P. M. Festen, Ed Schenk, Gie Tan, Pleun Snel & Frits Nelis. (1999) Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment. American Journal of Gastroenterology 94:4, pages 931-936.
Crossref
Lars Lundell & John Dent. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors 223 235 .
Bate, Green, Axon, Tildesley, Murray, Owen, Emmas & Taylor. (2001) Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD‐associated heartburn and the occurrence of underlying oesophagitis. Alimentary Pharmacology & Therapeutics 12:1, pages 41-47.
Crossref
L. LUNDELL. (2010) New information relevant to long-term management of endoscopy-negative reflux disease. Alimentary Pharmacology & Therapeutics 11, pages 93-98.
Crossref
K. LAURITSEN. (2010) Management of endoscopy-negative reflux disease: progress with short-term treatment. Alimentary Pharmacology & Therapeutics 11, pages 87-92.
Crossref
John M. Wo & J. Patrick Waring. (1997) MEDICAL THERAPY OF GASTROESOPHAGEAL REFLUX AND MANAGEMENT OF ESOPHAGEAL STRICTURES. Surgical Clinics of North America 77:5, pages 1041-1062.
Crossref
R. Carlsson, J.‐P. Galmiche, J. Dent, L. Lundell & L. Frison. (2003) Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials. Alimentary Pharmacology & Therapeutics 11:3, pages 473-482.
Crossref
R.E. Pounder. 1997. 316 325 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.